foxo4 dri senolytic peptide study FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes Targeted Apoptosis of Senescent Cells

Schoenenberger and Marcel Monnier University of Basel, Switzerland Primary Benefits Significantly improves delta-wave deep sleep, reduces nighttime awakenings, and helps establish healthy sleep patternsdemonstrated in multiple human clinical trials Documented stress-protective properties that help the body handle daily pressures while improving overall coping ability and resilience Described as 'incredibly safe' in research literature with no lethal dose identified in animal studies and minimal side effects in human trials spanning decades Amino Acid Sequence Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu (WAGGDASGE) Dosing How much do I take

doi:10.1016/s0006-3223(97)00277-1

Proposed mechanisms include upregulation of growth factor receptors, stimulation of fibroblast migration and collagen synthesis, and promotion of angiogenesis at injury sites

2000 Apr;129(4):355-6